• EcoSynthetix’s Q3 2026 net loss more than doubled year over year to USD 258,668.
• Net sales fell 38% year over year to USD 3.65 million due to lower volumes.
• A new commercial account with a global top-five tissue producer is using SurfLock at one facility and extending trials to others.
• CEO Jeff MacDonald said adoption was slower than anticipated, with two key strategic accounts continuing to use biopolymers at reduced levels.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EcoSynthetix Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202611031700CANADANWCANADAPR_C8117) on November 03, 2026, and is solely responsible for the information contained therein.